Importance of local tumour control in breast cancer

Lancet Oncology

Volumn 2, Issue 1, 2001, Pages 11-17

  Wong, Julia S ^a   Harris, Jay R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; HUMAN; MASTECTOMY; METHODOLOGY; MORTALITY; RADIOTHERAPY; REVIEW; SURVIVAL RATE;

BREAST NEOPLASMS; HUMANS; MASTECTOMY; RADIOTHERAPY; SURVIVAL RATE;

EID: 0035240659     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(00)00190-X     Document Type: Review

References (57)

1. Halsted W.S. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 46:1907;1.
2. Veronesi U., Valagussa P. Inefficacy of internal mammary node dissection in breast cancer surgery. Cancer. 47:1981;170-175.
3. Turner L., Swindell R., Bell R. Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl. 63:1981;239-243.
4. Maddox W., Carpenter J., Laws H., et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg. 198:1983;207-212.
5. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 312:1985;674-681.
6. Bonadonna G., Brusamolino E., Valagussa P., et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 294:1976;405-410.
7. Fisher B., Redmond C., Elias E.G., et al. Adjuvant chemotherapy for breast cancer: an overview of NSABP findings. Int Adv Surg Oncol. 5:1982;65-90.
8. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
9. Overgaard M., Jensen M., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 353:1999;1641-1648.
10. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
11. Veronesi U., Salvadori B., Luini A., et al. Breast conservation is a safe method in patients with small cancer of the breast: long-term results of three randomized trials on 1993 patients. Eur J Cancer. 31A:1995;1574-1579.
12. Fisher B., Anderson S., Redmond C.K., Wolmark N., Wickerham D.L., Cronin W.M. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 333:1995;1456-1461.
13. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 332:1995;907-911.
14. van Dongen J.A., Bartelink H., Fentiman I.S., et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 11:1992;15-18.
15. Arriagada R., Le M.G., Rochard F., Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol. 14:1996;1558-1564.
16. Blichert-Toft M., Rose C., Andersen J.A., et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr. 11:1992;19-25.
17. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 18:2000;1668-1675.
18. Anscher M.S., Jones P., Prosnitz L.R., et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg. 218:1993;22-28.
19. Smitt M.C., Nowels J.W., Zdeblich M.J., et al. The importance of lumpectomy surgical margin status in long term results of breast conservation. Cancer. 76:1995;259-267.
20. Holland R., Connolly J., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 8:1990;113-118.
21. Schnitt S., Connolly J., Khettry U., et al. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer. 59:1987;675-681.
22. Harris J.R. Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int J Radiat Oncol Biol Phys. 35:1996;641-648.
23. Lim M., Nixon A.J., Gelman R., et al. A prospective study of conservative surgery (CS) alone without radiotherapy (RT) in selected patients with stage I breast cancer. Breast Cancer Res Treat. 57:1999;34.
24. Fisher B., Dignam J., Mamounas H.P., et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight year results from NSABP B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate and fluorouracil. J Clin Oncol. 14:1996;1982-1992.
25. Fisher B., Dignam J., Bryant J., et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 88:1996;1529-1542.
26. Dalberg K., Johansson H., Johansson U., Rutqvist L. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy for patients with early stage breast carcinoma treated with breast conserving surgery. Cancer. 82:1998;2204-2211.
27. Wolmark N, Dignam J, Margolese R, Wickerham DL, Fisher B. The role of radiotherapy and tamoxifen in the management of node negative invasive breast cancer <1.0 cm treated with lumpectomy: preliminary results of NSABP protocol B-21. Proc Am Soc Clin Oncol 2000 (abstr 271).
28. Pinder S.E., Ellis I.O., Galea M., O'Rouke S., Blamey R.W., Elston C.W. Pathological prognostic factors in breast cancer, III: vascular invasion - relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 24:1994;41-47.
29. Bedwinek J., Lee J., Fineberg B., Ocwieza M. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer. 47:1981;2232-2235.
30. Jones J.M., Ribeiro G.G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol. 40:1989;204-208.
31. Host H., Brennhovd I.O., Loeb M. Postoperative radiotherapy in breast cancer: long-term results from the Oslo study. Int J Radiat Oncol Biol Phys. 12:1986;727-732.
32. Rutqvist L.E., Lax I., Fornander T., Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 22:1992;887-896.
33. Rutqvist L., Pettersson D., Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up in a randomized clinical trial. Radiother Oncol. 26:1993;104-110.
34. Fentiman I.S. Long-term follow-up of the first breast conservation trial: Guy's wide excision study. The Breast. 9:2000;5-8.
35. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 17:1999;1689-1700.
36. Stefanik D., Goldberg R., Byrne P., et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 3:1985;660-665.
37. Pisansky T.M., Ingle J.N., Schaid D.J., et al. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer: impact of clinical, histopathologic and flow cytometric factors. Cancer. 72:1993;1247-1260.
38. Whelan T.J., Julian J., Wright J., Jadad A.R., Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 18:2000;1220-1229.
39. Nixon A.J., Manola J., Gelman R., et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 16:1998;1374-1379.
40. Hojris I., Overgaard M., Christensen J.J., Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Lancet. 354:1999;1425-1430.
41. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757-70.
42. Larson D., Weinstein M., Goldberg I., et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 12:1986;1575-1582.
43. Lingos T.I., Recht A., Vicini F., Abner A., Silver B., Harris J.R. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 21:1991;355-360.
44. Pierce S.M., Recht A., Lingos T.I., et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 23:1992;915-923.
45. Taghian A., de Vathaire F., Terrier P., et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys. 21:1991;361-367.
46. Kurtz J.M., Amalric R., Brandone H., Ayme Y., Spitalier J.M. Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. Int J Radiat Oncol Biol Phys. 15:1988;277-284.
47. Badwe R.A., Hanby A.M., Fentiman I.S., Chaudary M.A. Angiosarcoma of the skin overlying an irradiated breast. Breast Cancer Res Treat. 19:1991;69-72.
48. de la Rochefordiere A., Abner A.L., Silver B., Vicini F., Recht A., Harris J.R. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys. 23:1992;925-931.
49. Moulds J.E.C., Berg C.D. Radiation therapy and breast reconstruction. Radiat Oncol Invest. 6:1998;81-89.
50. Tran N.V., Evans G.R.D., Kroll S.S., et al. Postoperativeadjuvant irradiation: effects on transverse rectus abdominismuscle flap breast reconstruction. Plast Reconstr Surg. 106:2000;313-317.
51. Veronesi U., Cascinelli N., Greco M., et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 202:1985;702-707.
52. Lu H, Cash E, Nixon A, et al. The impact of CT-simulation on the planning of tangential fields for left breast treatment. Proceedings of the American Society for Therapeutic Radiology and Oncology 41st Annual Meeting 1999; 45 (3 suppl): 159.
53. Hardenbergh P.H., Bentel G.C., Prosnitz L.R., Marks L.B. Postmastectomy radiotherapy: toxicities and techniques to reduce them. Semin Radiat Oncol. 9:1999;259-268.
54. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst. 88:1996;1659-1664.
55. Renton S.C., Gazet J.C., Ford H.T., Corbishley D., Sutcliffe R. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol. 22:1996;17-22.
56. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet. 348:1996;708-713.
57. Liljegren G., Holmberg L., Adami H.O., Westman G., Graffman S., Bergh J. Sector resection with and without postoperative radiotherapy for stage I breast cancer: five year results of a randomized trial. J Natl Cancer Inst. 86:1994;717-722.